Mesh.i
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Medicare »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Medical Records Systems, Computerized < Medicare < Medication Adherence  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000891 (2013) Jeffrey R. Curtis [États-Unis] ; Fenglong Xie ; Rui Chen ; Lang Chen ; Meredith L. Kilgore ; James D. Lewis ; Huifeng Yun ; Jie Zhang ; Nicole C. Wright ; Elizabeth DelzellIdentifying newly approved medications in Medicare claims data: a case study using tocilizumab.
000B96 (2015) Huifeng Yun ; Fenglong Xie ; Elizabeth Delzell ; Lang Chen ; Emily B. Levitan ; James D. Lewis ; Kenneth G. Saag ; Timothy Beukelman ; Kevin Winthrop ; John W. Baddley ; Jeffrey R. CurtisRisks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
000C50 (2015) Jie Zhang ; Fenglong Xie ; Elizabeth Delzell ; Huifeng Yun ; James D. Lewis ; Kevin Haynes ; Lang Chen ; Timothy Beukelman ; Kenneth G. Saag ; Jeffrey R. CurtisImpact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.
000F10 (2016) Huifeng Yun ; Fenglong Xie ; Elizabeth Delzell ; Emily B. Levitan ; Lang Chen ; James D. Lewis [États-Unis] ; Kenneth G. Saag ; Timothy Beukelman ; Kevin L. Winthrop [États-Unis] ; John W. Baddley ; Jeffrey R. CurtisComparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.
001190 (2016) Fenglong Xie ; Huifeng Yun ; Sasha Bernatsky [Canada] ; Jeffrey R. Curtis [États-Unis]Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.
001378 (2017) Huifeng Yun ; Fenglong Xie ; Randall N. Beyl ; Lang Chen ; James D. Lewis [États-Unis] ; Kenneth G. Saag ; Jeffrey R. CurtisRisk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Medicare" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Medicare" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Medicare
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021